This company has been acquired
このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
DICE Therapeutics バランスシートの健全性
財務の健全性 基準チェック /66
DICE Therapeutics has a total shareholder equity of $519.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $550.7M and $31.6M respectively.
主要情報
0%
負債資本比率
US$0
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$528.38m |
| エクイティ | US$519.06m |
| 負債合計 | US$31.62m |
| 総資産 | US$550.67m |
財務の健全性に関する最新情報
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14
Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18財務状況分析
短期負債: DICE's short term assets ($532.3M) exceed its short term liabilities ($20.6M).
長期負債: DICE's short term assets ($532.3M) exceed its long term liabilities ($11.0M).
デット・ツー・エクイティの歴史と分析
負債レベル: DICE is debt free.
負債の削減: DICE had no debt 5 years ago.
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: DICE has sufficient cash runway for more than 3 years based on its current free cash flow.
キャッシュランウェイの予測: DICE has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 46.7% each year.